By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Source MDx 

2500 Central Avenue, Suite 209

Boulder  Colorado  80301  U.S.A.
Phone: 303-385-2700 Fax: 303-385-2750



Company News
Source MDx Announces 16 Molecular Diagnostic Development Programs Will Be Offered for Sale on April 29, 2011 3/29/2011 9:59:12 AM
Source MDx Announces Foundational Patents Will Be Offered for Sale on April 29, 2011 3/22/2011 9:22:54 AM
Dana-Farber Cancer Institute Oncologists Present Results of Source MDx's RNA Transcript-Based Six-Gene Test to Predict Survival of Castration-Resistant Prostate Cancer Patients at GU ASCO Symposium 2/27/2009 9:50:42 AM
Source MDx Announces Partnership With Brigham and Women's Hospital to Study RNA-Based Biomarkers for Multiple Sclerosis 11/3/2008 9:12:29 AM
XDx, Inc. Files Reexamination Request for Source MDx Patent 2/15/2008 9:13:40 AM
Source MDx Announces Translational Molecular Medicine Collaboration With Pfizer Inc. (PFE) 12/27/2007 8:41:49 AM
Source MDx to Participate in Breakout Session Focused on Companion Diagnostics at the 2007 Biotechnology Industry Organization (BIO) International Convention 5/3/2007 3:42:40 PM
Tufts-New England Medical Center And Source MDx Will Collaborate To Investigate The Clinical Use Of RNA-based Biomarkers To Monitor RA Disease Status And Response To Therapy 11/9/2006 11:12:34 AM
Source MDx Launches OncoProfiling(SM) Biomarker Services For Targeted Oncology Drug Development 9/15/2006 11:10:22 AM
University of Colorado At Denver And Health Sciences Center And Source MDx Form Research Collaboration To Develop Molecular Diagnostics For Melanoma And Psoriasis 6/1/2006 12:23:26 PM